โš™

Pathophysiology Nodes

4
4 shared nodes are defined in this module.
โ—‰

Cell Types

0
No cell types are annotated for this module.
โ‡„

Biological Processes

5
Epithelial to Mesenchymal Transition GO:0001837 INCREASED Negative Regulation of Cell Adhesion GO:0007162 INCREASED Cell Migration GO:0016477 INCREASED Extracellular Matrix Organization GO:0030198 INCREASED Cell Population Proliferation GO:0008283 INCREASED
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "invasion_and_metastasis#Local Invasion and Intravasation" or "invasion_and_metastasis#Metastatic Colonization"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding cell types, biological processes, and causal edges, specialized to their tumor context. Key tumor-specific substitutions: carcinomas use classical E-cadherin-loss EMT; organotropism (Paget "seed and soil") substitutes the target organ and its premetastatic niche. Key conformance target: "invasion_and_metastasis#Metastatic Colonization".
โ†—

Used By Disorder Entries

2
โฌก

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Activating Invasion and Metastasis Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
โš™

Pathophysiology

4
Epithelial-Mesenchymal Transition Activation
trigger
Tumor cells reactivate the latent embryonic EMT program. EMT transcription factors (SNAIL, SLUG, ZEB1/2, TWIST), induced by TGF-beta, Wnt, and signals from the tumor stroma, repress E-cadherin and other epithelial genes and induce mesenchymal markers. Cells lose apical-basal polarity and cell-cell adhesion and acquire a motile, invasive phenotype. EMT is typically partial and reversible (epithelial-mesenchymal plasticity), enabling later reversion (MET) at the metastatic site.
Epithelial to Mesenchymal Transition GO:0001837 INCREASED Negative Regulation of Cell Adhesion GO:0007162 INCREASED
Local Invasion and Intravasation
effector
Motile tumor cells invade locally, degrading the basement membrane and extracellular matrix with matrix metalloproteinases and other proteases and migrating through the stroma, often led by invadopodia and aided by tumor-associated macrophages and cancer-associated fibroblasts. Invading cells reach and penetrate the walls of blood or lymphatic vessels (intravasation), entering the circulation.
Cell Migration GO:0016477 INCREASED Extracellular Matrix Organization GO:0030198 INCREASED
Circulatory Survival and Extravasation
effector
As circulating tumor cells, disseminating cells must survive loss of matrix attachment (resisting anoikis), shear stress, and immune surveillance, sometimes shielded by platelet cloaking. Surviving cells arrest in the microvasculature of a distant organ and extravasate across the endothelium into the parenchyma, a step shaped by organ-specific adhesion and chemokine cues.
Cell Migration GO:0016477 INCREASED
Metastatic Colonization
consequence
Extravasated cells must adapt to the foreign microenvironment of the distant organ and re-initiate proliferation to form a clinically relevant macrometastasis. Most disseminated cells fail this step or enter prolonged dormancy; colonization is the rate-limiting and least efficient stage of the cascade, often requiring establishment of a supportive (pre-metastatic) niche and frequently a reversion toward an epithelial state (MET). Successful colonization produces the metastases responsible for most cancer mortality.
Cell Population Proliferation GO:0008283 INCREASED